Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7896]

ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma

ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma

ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition

ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition

ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results

ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results

ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma

ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma

ASH 2019: Novel off-the-shelf CAR NK product overcomes CD19 antigen escape in preclinical studies

ASH 2019: Novel off-the-shelf CAR NK product overcomes CD19 antigen escape in preclinical studies

ASH 2019: High response rate seen with BCMA-directed CAR T-cell therapy for multiple myeloma

ASH 2019: High response rate seen with BCMA-directed CAR T-cell therapy for multiple myeloma

Updated NCCN genetic screening guidelines feature emerging evidence on personalised medicine

Updated NCCN genetic screening guidelines feature emerging evidence on personalised medicine

New, non-hormonal target identified for advanced prostate cancer

New, non-hormonal target identified for advanced prostate cancer

Colorado study suggests new strategies against bone metastases from prostate cancer

Colorado study suggests new strategies against bone metastases from prostate cancer

Researchers find common measures of immune status, inflammation can predict mortality

Researchers find common measures of immune status, inflammation can predict mortality

More from ecancer